硬化治疗与电灼/激光治疗遗传性出血性毛细血管扩张症鼻出血的比较
这项回顾性研究纳入67例中重度鼻出血的遗传性出血性毛细血管扩张症患者,比较电灼/激光(C±L,34例)与十四烷基硫酸钠硬化治疗(STS,33例)。结果显示STS维持鼻出血严重程度评分为轻度所需操作次数显著更少,术后鼻结痂、恶臭和鼻中隔穿孔发生率更低,血红蛋白、铁储备、血液学支持和生活质量无显著差异。
要点
- STS术后鼻结痂、恶臭和鼻中隔穿孔发生率均显著低于C±L。
- 两组血红蛋白、铁储备、血液学支持和生活质量评分无显著差异。
核心结论
- STS能以显著更少的操作次数和更低的术后并发症达到满意的鼻出血控制。
- STS应被考虑作为HHT患者鼻出血的初始手术治疗选择。
研究设计与样本
- 回顾性研究,纳入67例中重度鼻出血的HHT患者,C±L组34例,STS组33例。
主要发现
- 两组血红蛋白水平、铁储备、血液学支持和生活质量评分无显著差异。
临床怎么用
- 对于HHT相关鼻出血,可优先考虑STS作为初始手术治疗以降低操作次数和并发症。
局限性
- 回顾性研究设计,证据等级为4级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: Surgical interventions for epistaxis management in hereditary hemorrhagic telangiectasia (HHT) demonstrate short-term success and require repeated procedures for disease control. Although electrocautery and/or laser photocoagulation (C ± L) are most frequently performed, sodium tetradecyl sclerotherapy (STS) is emerging as a promising newer treatment. We hypothesized that in a 24-month time period, STS would require fewer treatments than C ± L to maintain epistaxis severity within the mild range. STUDY DESIGN: Retrospective study. METHODS: We retrospectively assessed 67 patients with HHT with moderate and severe epistaxis that were treated periodically with C ± L (34 patients) versus STS (33 patients). The primary outcome was the number of procedures needed to maintain the epistaxis severity score (ESS) as mild. Secondary outcomes assessed for differences in postoperative complications, hemoglobin levels, iron stores, hematologic support, and quality-of-life (QoL) scores. RESULTS: To maintain ESS in the mild range, 1.6 STS procedures (range, 1-4) were performed versus 3.6 C ± L procedures (range, 1-8) (P = .003). Significant postoperative differences included reduction in nasal crusting (3% vs. 32%, P = .001), foul odor (3% vs. 35%, P < .001), and septal perforation (3% vs. 29%, P = .006) after STS. There were no significant differences between the two treatments in hemoglobin levels, iron stores, hematologic support, or QoL scores. CONCLUSION: STS is able to attain satisfactory epistaxis control with significantly fewer procedures and lower postoperative complications than C ± L. STS should be considered as the initial surgical intervention for epistaxis in patients with HHT. LEVEL OF EVIDENCE: 4 Laryngoscope, 132:920-925, 2022.
引用
- Woodard TD, Yappel-Sinkko KB, Wang X, et al. Sclerotherapy Versus Cautery/Laser Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia. Laryngoscope. 2021. PMID: 34160081. doi:10.1002/lary.29701
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。